Gynecological
Pelvic mesh lawsuits: Internal Bard memo shows medical device company knew mesh was unfit for humans
M&A: Bayer buys Conceptus for $1.1 billion
C.R. Bard loses patent round, $25M hernia insurance decision
Analysts defend Intuitive Surgical as docs defend robot-assisted surgery
Updated March 18, 2013, at 2:15 p.m. with a correction.
Analysts “surprised” at sudden Intuitive Surgical sell-off
Intuitive Surgical (NSDQ:ISRG) shares suffered a sudden sell-off today after the American Congress of Obstetricians & Gynecologists released a statement questioning some of the marketed benefits of robot-assisted surgery.
MassDevice.com +3 | The top 3 med-tech stories for Jan. 15, 2013
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Medtronic: Study shows InterStim neurostim device helps overactive bladder
Reducing C-section births: MindChild Medical gets FDA win for fetal heart monitor
MindChild Medical received 510(k) clearance from the U.S. FDA for a new fetal heart monitor the company says can detect tiny fluctuations in fetal heartbeats and potentially reduce the number of Caesarean sections pregnant women undergo.
Company officials said the regulatory win clears the way for the company to commercialize its Meridian non-invasive fetal heart monitor.
FDA probes JNJ, Bard and others on transvaginal mesh risks
Conceptus names new CEO, lowers 2012 guidance | Personnel Moves
In a sudden switch, Conceptus (NSDQ:CPTS) named Keith Grossman president & CEO upon the resignation of Mark Sieczkarek, whose departure was announced on the heels of lowered sales guidance for 2012.
Sieczkarek’s resignation, after 7 years at the helm, was announced simultaneously with Grossman’s appointment. Grossman will join the company’s board of directors, from which Sieczkarek also resigned.